<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26780" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Peak Flow Rate Measurement</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>DeVrieze</surname>
            <given-names>Bradley W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldin</surname>
            <given-names>Jennifer</given-names>
          </name>
          <aff>Wright State University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Giwa</surname>
            <given-names>Al O.</given-names>
          </name>
          <aff>Icahn School of Medicine at Mount Sinai</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bradley DeVrieze declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Goldin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Al Giwa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26780.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Peak expiratory flow (PEF) measurement is critical in asthma management, particularly when spirometry is unavailable. Measured using widely accessible peak flow meters, PEF offers an objective assessment of airflow limitation and helps guide asthma control and treatment decisions. Proper technique is essential for accurate results, highlighting the importance of patient education. Monitoring PEF regularly aids in evaluating the effectiveness of therapy and provides an early indication of asthma exacerbations. Personalized asthma action plans, developed based on individual PEF values, enable more precise therapeutic adjustments and early intervention.</p>
        <p>PEF measurement is also integral to managing acute asthma exacerbations, especially in adolescents and adults. While used less frequently during pediatric exacerbations, the technique remains valuable in routine asthma care. Clinicians must ensure patients understand how to use the device correctly and interpret the results to optimize outcomes. Adhering to standardized guidelines for PEF meters and ensuring devices meet established criteria further enhances the reliability of measurements in clinical practice.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify appropriate candidates for peak flow rate measurement based on clinical indications, such as suspected asthma, severity monitoring, or&#x000a0;treatment response assessment.</p></list-item><list-item><p>Screen patients for proper technique and provide tailored education on the correct use of peak flow meters to optimize data accuracy.</p></list-item><list-item><p>Apply evidence-based guidelines to interpret peak flow data and make informed decisions regarding asthma management.</p></list-item><list-item><p>Implement strategies to collaborate with other healthcare team members to integrate peak flow measurement into comprehensive asthma management protocols.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26780&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26780">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26780.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Peak expiratory flow (PEF), a key indicator of lung function, offers clinicians valuable insights into asthma management. Typically measured with a peak flow meter, PEF provides an objective measure of airflow limitation, aiding in assessing asthma control and managing exacerbations (see&#x000a0;<bold>Image.</bold>&#x000a0;Peak Flow Meter).<xref ref-type="bibr" rid="article-26780.r1">[1]</xref>&#x000a0;A maximal effort is required when using a peak flow meter to obtain valid results.<xref ref-type="bibr" rid="article-26780.r2">[2]</xref> The depth of the preceding breath, airway caliber, muscle strength, and voluntary effort all&#x000a0;contribute to PEF.&#x000a0;Clinicians should observe patients using a peak flow meter to identify suboptimal effort or technique. However, variability exists between devices, and no good technique exists to calibrate readings between different flow meters.<xref ref-type="bibr" rid="article-26780.r3">[3]</xref>&#x000a0;The International Organization for Standardization has published guidelines for PEF meters; clinicians and patients should choose devices that meet these criteria.</p>
        <p>Once a patient establishes a personal best, clinicians can create an individualized asthma action plan, including instructions the patient can follow at home.&#x000a0;Routine monitoring of a PEF aids in determining the effectiveness of therapy, provides an early warning of potential exacerbations, and can be especially helpful for patients with difficulties recognizing asthma symptoms. PEF measurement can also assess the severity and response to treatment during an acute asthma exacerbation in adolescents and adults. PEF is assessed less commonly during&#x000a0;acute exacerbations in younger children.&#x000a0;With personalized action plans based on individual PEF values, clinicians can&#x000a0;provide early intervention and optimized maintenance therapy,&#x000a0;improving management and outcomes for patients with asthma.<xref ref-type="bibr" rid="article-26780.r4">[4]</xref></p>
      </sec>
      <sec id="article-26780.s3" sec-type="Indications">
        <title>Indications</title>
        <p>The primary indication for a PEF measurement is self-assessment and self-management of asthma symptoms based on a written action plan. Patients follow written instructions based on their symptoms and peak flow measurements. Studies reveal that a written action plan reduces asthma morbidity in adults and children.<xref ref-type="bibr" rid="article-26780.r5">[5]</xref><xref ref-type="bibr" rid="article-26780.r6">[6]</xref><xref ref-type="bibr" rid="article-26780.r7">[7]</xref>&#x000a0;Monitoring the PEF may be especially helpful for patients&#x000a0;who have difficulty recognizing asthma symptoms or exacerbating factors.<xref ref-type="bibr" rid="article-26780.r8">[8]</xref> Additional indications for using a peak flow meter&#x000a0;include&#x000a0;assessing severity and the response to treatment during acute asthma exacerbations in adults and adolescents, home monitoring of asthma, and assessing occupational asthma. Due to effort and technique requirements, clinicians rarely use peak flow measurements to measure the severity of an acute exacerbation in children younger than 12.&#x000a0;Patients suspected of having occupational asthma may benefit from serial peak flow measurements at and&#x000a0;outside the&#x000a0;workplace.<xref ref-type="bibr" rid="article-26780.r9">[9]</xref><xref ref-type="bibr" rid="article-26780.r10">[10]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26780.s4" sec-type="Equipment">
        <title>Equipment</title>
        <p>Various peak flow meters are available for purchase. The&#x000a0;standard peak flow meter&#x000a0;is a simple cylindrical handheld device with a mouthpiece and an indicator with measurements along the body that patients can reuse many times. Some electronic meters can record and transmit the readings to the provider. Handheld electronic spirometers that measure FVC, FEV1, and PEF are also available for home use.</p>
      </sec>
      <sec id="article-26780.s5" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Despite the various designs of peak flow meters, they all operate using the same basic technique. Clinicians should&#x000a0;instruct&#x000a0;the patient to perform the following process:</p>
        <list list-type="order">
          <list-item>
            <p>Move the indicator to 0.</p>
          </list-item>
          <list-item>
            <p>Stand or sit up straight.</p>
          </list-item>
          <list-item>
            <p>Take in a breath as deep as possible.</p>
          </list-item>
          <list-item>
            <p>Place the meter in the mouth and close the lips around the mouthpiece, ensuring the tongue is not blocking or inside the opening.</p>
          </list-item>
          <list-item>
            <p>As soon as the lips are closed, blow out as hard and fast as possible, using the chest and abdominal muscles. This should take no more than 2 seconds.</p>
          </list-item>
          <list-item>
            <p>Write down the result.</p>
          </list-item>
          <list-item>
            <p>Repeat the steps above 2 more times.</p>
          </list-item>
          <list-item>
            <p>Report&#x000a0;the highest result to your provider.</p>
          </list-item>
        </list>
        <p>The clinician should observe the patient's technique during in-office education and assist with necessary adjustments. Clinicians should also review the technique at subsequent follow-up visits. Peak flow rates in individual patients tend to decrease over time, likely from waning skill and effort.<xref ref-type="bibr" rid="article-26780.r11">[11]</xref>&#x000a0;This observation highlights the need for ongoing retraining of techniques after the initial clinic visit. Some authors recommend retraining at every follow-up visit in conjunction with inhaler retraining.<xref ref-type="bibr" rid="article-26780.r12">[12]</xref>&#x000a0;Clinicians should reestablish patients' personal best annually to&#x000a0;assess for growth in children and disease progression.</p>
      </sec>
      <sec id="article-26780.s6" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Ideally, patients establish a personal best peak flow rate when feeling well.<xref ref-type="bibr" rid="article-26780.r13">[13]</xref>&#x000a0;Patients should record their peak flow values in a diary 2 to 4 times daily for 2 weeks. The personal best is the highest peak flow measured during this time. A personal best peak flow value can be higher or lower than the predicted value. Clinicians then use the patient's personal best to create an action plan for self-monitoring and managing acute exacerbations. Studies&#x000a0;have indicated that an action plan improves asthma control and quality of life.<xref ref-type="bibr" rid="article-26780.r6">[6]</xref>&#x000a0;</p>
        <p>Clinicians should be cautioned against over-reliance on peak flow measurements alone. Studies evaluating the overall outcomes when utilizing peak flow measurement alone show conflicting results and reveal no advantage of using PEF monitoring over symptom monitoring to guide self-management.<xref ref-type="bibr" rid="article-26780.r14">[14]</xref>&#x000a0;Society guidelines have suggested a comprehensive approach that accounts for both subjective symptoms and objective data from the peak flow meter. Data show that this approach can decrease healthcare utilization.</p>
        <p>Typical peak flow meters come equipped with gauge markers indicating 3 "zones" that can be set by the patient or clinician to help users interpret their peak flow values. For ease of patient interpretation, the colors of a traditional traffic light designate varying degrees of peak flow limitation. The designated zones correlate with a written asthma action plan.</p>
        <p><bold>Green zone:&#x000a0;</bold>This zone designates peak flow values of 80% to 100% of the patient's personal best. In the absence of symptoms, the patient continues with their current regimen.</p>
        <p><bold>Yellow zone:</bold>&#x000a0;The yellow zone encompasses peak flow values between 50% and 80% of the patient's personal best. Patients employ their home action plan, beginning with bronchodilators, when they identify readings in this zone.<xref ref-type="bibr" rid="article-26780.r15">[15]</xref></p>
        <p><bold>Red zone:</bold>&#x000a0;Patients in the red zone have peak flow measurements below 50% of their personal best. They should begin bronchodilator therapy immediately and contact their clinician if their peak flow measurements do not immediately return to the yellow or green zones. Peak flow measurements in this range&#x000a0;indicate that severe airway obstruction may be present and is a medical emergency. See StatPearls' companion references "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/17920">Asthma</ext-link>"&#x000a0;and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/26821">Pediatric Asthma</ext-link>" for a detailed description of the management of acute asthma exacerbations in adults and children.</p>
        <p>PEF measurement is also helpful in guiding disposition in the emergency setting. A patient with a peak flow rate of less than 50% without improvement despite aggressive therapy warrants hospital admission for ongoing care and close monitoring for signs of impending respiratory failure. Respiratory therapists and nurses can obtain and report serial peak flow measurements throughout the hospital course to guide disposition decisions. In the inpatient setting, patients often do not know their personal best. In this situation, published tables of normal PEF rates for height and weight are available. Generally, a peak flow rate below 200 L/min indicates severe obstruction for most adults younger than 65.</p>
        <p>
<bold>Special Populations</bold>
</p>
        <p>
<bold>Pediatrics</bold>
</p>
        <p>Children aged 5 or older can use the peak flow meter with reliable results. However, cooperation with the technique may limit the accuracy during acute exacerbations, and clinicians should interpret the results cautiously. For this reason, healthcare professionals do not routinely use peak flow measurements during acute asthma exacerbations in children. Tables of normal peak flow rates are available for children and adolescents. Additionally, when children use a peak flow monitor for self-management and assessment, clinicians should consider providing a second meter for the child to keep at school in the nurse's office should concerns arise.</p>
        <p>
<bold>Pregnancy</bold>
</p>
        <p>Despite body changes associated with pregnancy, peak flow rate and personal best numbers do not change through each trimester&#x000a0;or during the postpartum period. Changes in the observed PEF in pregnant women should be treated as worsening obstruction until proven otherwise.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/edit//167484?Return=https://www.statpearls.com/home/contributordashboard/#ref_9052590">[6]</ext-link></p>
        <p>
<bold>Limitations</bold>
</p>
        <p>As mentioned previously, suboptimal effort can lead to falsely decreased readings. Chest wall disease, obesity, and muscle weakness can also reduce PEF without airflow limitation.&#x000a0;In patients with severe asthma, peak flow measurement can underestimate the degree of airflow limitation.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/edit/167484/?Return=https%3A%2F%2Fwww.statpearls.com%2Fhome%2Fcontributordashboard%2F#ref_12298428">[14]</ext-link>&#x000a0;Patients often have difficulty adhering to long-term peak flow monitoring.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/keywords/edit/167484/?Return=https%3A%2F%2Fwww.statpearls.com%2Fhome%2Fcontributordashboard%2F#ref_9554633">[15]</ext-link>&#x000a0;Routine measurement is most effective when limited to shorter periods.</p>
      </sec>
      <sec id="article-26780.s7" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Peak flow measurement reflects the maximal exhalation rate following full inspiration, making it a valuable tool for asthma management. Peak flow values objectively measure airflow limitation when spirometry is unavailable.&#x000a0;Clinicians and other team members must possess the skills to accurately measure and interpret peak flow values, including proficiency in instructing patients on proper technique and integrating results into clinical decision-making. Patient education on proper technique is essential, as validity hinges on maximal effort, and factors such as the depth of the preceding breath, airway caliber, and muscle strength influence results. After a patient's personal best is established, peak flow guides in creating an asthma action plan, symptom self-management, and assisting in treating acute exacerbations. Color-coded zones modeled after a traditional traffic light simplify interpretation and give patients a clear understanding of necessary management based on their symptoms and peak flow measurements. Interpretation in pediatric patients requires care due to potential limitations in technique.</p>
        <p>Developing standardized protocols and guidelines ensures consistency and promotes best practices across disciplines. Effective interprofessional communication ensures seamless care coordination, involving sharing information, clarifying roles, and addressing concerns. Care coordination efforts prioritize patient education, empowerment, and engagement in self-management, ensuring thorough asthma management and optimal use of peak flow measurement. Prioritizing patient-centered care promotes collaboration, trust, and treatment plan adherence, ultimately reducing morbidity and improving healthcare team performance.</p>
      </sec>
      <sec id="article-26780.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26780&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26780">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26780/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26780">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26780.s9">
        <fig id="article-26780.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Peak Flow Meter Contributed by B DeVrieze, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_5483" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26780.s10">
        <title>References</title>
        <ref id="article-26780.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathod</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Budensab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhalla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahesh</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Alex</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jesudas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Spirometric Assessment of Pulmonary Function Tests in Asthma Patients.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>e54979</fpage>
            <pub-id pub-id-type="pmid">38550448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyejo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Matillya</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ismail</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gachocha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salum</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iseme</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Noorani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The anthropometric determinants of peak expiratory flow rate among children in Dar Es Salaam, Tanzania.</article-title>
            <source>BMC Pediatr</source>
            <year>2024</year>
            <month>Jan</month>
            <day>13</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <pub-id pub-id-type="pmid">38218839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukioka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Comparison of different types of peak flow meter and reference values for peak expiratory flow (PEF) for healthy Japanese subjects].</article-title>
            <source>Nihon Rinsho</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>54</volume>
            <issue>11</issue>
            <fpage>2927</fpage>
            <page-range>2927-32</page-range>
            <pub-id pub-id-type="pmid">8950932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soumagne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chenivesse</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Didier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giovannini-Chami</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Magnan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taill&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
              <collab>et les investigateurs du groupe d&#x02019;&#x000e9;tude PAE</collab>
            </person-group>
            <article-title>[Written action plans for asthma control: How are they used by pulmonologists in France?].</article-title>
            <source>Rev Mal Respir</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-109</page-range>
            <pub-id pub-id-type="pmid">38228440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The relationship between changes in peak expiratory flow and asthma exacerbations in asthmatic children.</article-title>
            <source>BMC Pediatr</source>
            <year>2024</year>
            <month>Apr</month>
            <day>27</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>284</fpage>
            <pub-id pub-id-type="pmid">38678177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muhammad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ngah</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Written Asthma Action Plan Improves Asthma Control and the Quality of Life among Pediatric Asthma Patients in Malaysia: A Randomized Control Trial.</article-title>
            <source>Korean J Fam Med</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-52</page-range>
            <pub-id pub-id-type="pmid">36709960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gatheral</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Rushton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mulvaney</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Halcovitch</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Whiteley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eccles</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Personalised asthma action plans for adults with asthma.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Apr</month>
            <day>10</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD011859</fpage>
            <pub-id pub-id-type="pmid">28394084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnes</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Szefler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Reddel</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Chipps</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>144</volume>
            <issue>5</issue>
            <fpage>1180</fpage>
            <page-range>1180-1186</page-range>
            <pub-id pub-id-type="pmid">31330221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moscato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Godnic-Cvar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maestrelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-301</page-range>
            <pub-id pub-id-type="pmid">7560631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Burge</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Jaakkola</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Burge</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma.</article-title>
            <source>Eur Respir J</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>574</fpage>
            <page-range>574-8</page-range>
            <pub-id pub-id-type="pmid">19324953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Schoor</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>de Jongh</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Lips</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Deeg</surname>
                <given-names>DJH</given-names>
              </name>
              <name>
                <surname>Kok</surname>
                <given-names>AAL</given-names>
              </name>
            </person-group>
            <article-title>Long-term trajectories of peak expiratory flow rate in older men and women show linear decline mainly determined by baseline levels.</article-title>
            <source>Aging Clin Exp Res</source>
            <year>2024</year>
            <month>Apr</month>
            <day>16</day>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <pub-id pub-id-type="pmid">38627297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gannon</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Belcher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pantin</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Burge</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow.</article-title>
            <source>Eur Respir J</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-31</page-range>
            <pub-id pub-id-type="pmid">10489825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddel</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>When can personal best peak flow be determined for asthma action plans?</article-title>
            <source>Thorax</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>922</fpage>
            <page-range>922-4</page-range>
            <pub-id pub-id-type="pmid">15516464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tierney</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Roesner</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Seshadri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lykens</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Weinberger</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations.</article-title>
            <source>J Gen Intern Med</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-42</page-range>
            <pub-id pub-id-type="pmid">15009778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26780.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polk</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Dinakar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Management of acute loss of asthma control: yellow zone strategies.</article-title>
            <source>Curr Opin Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-160</page-range>
            <pub-id pub-id-type="pmid">30649012</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
